M. D. Harvey

Geotechnical and Hydraulic Stability Numbers for Channel Rehabilitation: Part I, the Approach

Phil G. Combs, Chester C. Watson, David S. Biedenharn, 1988 .

Utilization of the non-covalent fluorescent dye, NanoOrange, as a potential clinical diagnostic tool. Nanomolar human serum albumin quantitation.

M. D. Harvey, C. Skinner, P. Banks, 2001, Journal of chromatography. B, Biomedical sciences and applications.

Single-label fluorescent derivatization of peptides

M. D. Harvey, Michael J. Little, P. Banks, 1997 .

Compatibility and stability of the novel anti-cancer agent C1311 in infusion devices and its in vitro biocompatibility

M. D. Harvey, J. Beijnen, B. Nuijen, 2005, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Development and validation of an LC-UV method for the quantification and purity determination of the novel anticancer agent C1311 and its pharmaceutical dosage form.

M. D. Harvey, J. Beijnen, M. Hillebrand, 2005, Journal of pharmaceutical and biomedical analysis.

CLINICAL APPLICATIONS OF CE

Michael D. Harvey, M. D. Harvey, Donald M. Paquette, 2001 .

Subnanomolar detection limit for sodium dodecyl sulfate — capillary gel electrophoresis using a fluorogenic, noncovalent dye

M. D. Harvey, D. Bandilla, P. Banks, 1998, Electrophoresis.

Site-specific fluorescent derivatization and liquid chromatographic-mass spectrometric characterization of long R(3) IGF-I for bioanalytical applications.

M. D. Harvey, P. Banks, 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.